FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

702836004: Trastuzumab emtansine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3006212012 Trastuzumab emtansine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3006214013 Trastuzumab emtansine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
847141000172118 trastuzumab emtansine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trastuzumab emtansine Is a Trastuzumab (substance) false Inferred relationship Some
Trastuzumab emtansine Has disposition (attribute) Murine-human monoclonal immunoglobulin G antibody false Inferred relationship Some
Trastuzumab emtansine Has disposition (attribute) Immunomodulator (disposition) true Inferred relationship Some
Trastuzumab emtansine Is a Human epidermal growth factor receptor 2 inhibitor true Inferred relationship Some
Trastuzumab emtansine Has disposition (attribute) Human epidermal growth factor receptor 2 inhibitor true Inferred relationship Some
Trastuzumab emtansine Is a anticorps monoclonal chimérique souris-humain d'isotype IgG false Inferred relationship Some
Trastuzumab emtansine Is a Antineoplastic agent (substance) false Inferred relationship Some
Trastuzumab emtansine Is modification of (attribute) Trastuzumab (substance) false Inferred relationship Some
Trastuzumab emtansine Is a Enzyme inhibitor protein true Inferred relationship Some
Trastuzumab emtansine Is a Immunosuppressant (substance) true Inferred relationship Some
Trastuzumab emtansine Is a Monoclonal antibody true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Trastuzumab emtansine-containing product Has active ingredient True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine only product Has active ingredient True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine-containing product in parenteral dose form Has active ingredient True Trastuzumab emtansine Inferred relationship Some 1
Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form) Has active ingredient True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine 100 mg powder for solution for infusion vial Has basis of strength substance (attribute) True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine 100 mg powder for solution for infusion vial Has precise active ingredient True Trastuzumab emtansine Inferred relationship Some 1
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has basis of strength substance (attribute) True Trastuzumab emtansine Inferred relationship Some 1
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has precise active ingredient True Trastuzumab emtansine Inferred relationship Some 1
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Trastuzumab emtansine Inferred relationship Some 1
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Trastuzumab emtansine Inferred relationship Some 1
Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Trastuzumab emtansine Inferred relationship Some 1
Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Trastuzumab emtansine Inferred relationship Some 1
Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has precise active ingredient True Trastuzumab emtansine Inferred relationship Some 1
Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has basis of strength substance (attribute) True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial Has precise active ingredient True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial Has basis of strength substance (attribute) True Trastuzumab emtansine Inferred relationship Some 1

This concept is not in any reference sets

Back to Start